ClinicalTrials.gg
RecruitingNCT07710417PTSS FLOATUpdated Jul 17, 2026

FLOAT for Healthcare PTSS

An Early Phase 1 interventional study of Floatation-REST and Documentary in Posttraumatic Stress Symptoms, Burnout and Burnout, Healthcare Workers, sponsored by Laureate Institute for Brain Research, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Laureate Institute for Brain Research, Inc. · Early Phase 1, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Early Phase 1
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 149 studies in Burnout, Psychological with a site in United States — 29 open to participants now, 41 under way, none of them phase 3. Burnout, Psychological · United States.

Planned enrollment
120th of 134
15 · median 80
Started
2026
with 15 others
Phase 1
3 of 149
1 open now
Primary completion
2026-12
later than 14 of 40 live
Registered
140th of 149
by date

Among the 149 studies in Burnout, Psychological with a site in United States, this one is the 120th largest by planned enrollment of the 134 interventional ones that give a count, is one of 16 that started in 2026, is one of 3 in phase 1, reaches primary completion later than 14 of the 40 other live ones, and was the 140th registered.

Burnout, Psychological

468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

Browse Burnout, Psychological studies →

Open to participants now

29 of the 149 studies in Burnout, Psychological with a site in United States are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 65 Burnout, Psychological studies recruiting now, 43 (66%) set no upper age limit and 16 (25%) stop at 75 or younger; 14 take children under 18; 33 take healthy volunteers.

This study: 18 Years to 64 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 149 studies in Burnout, Psychological with a site in United States, or all of them as a file.
02

Study summary

This early-stage pilot trial aims to examine the feasibility, tolerability, and safety of Floatation-REST, or Reduced Environmental Stimulation Therapy via floatation in frontline healthcare workers, first responders, and emergency medical personnel who experience post-traumatic stress symptoms.

Read the detailed description

Frontline healthcare workers, first responders, and emergency medical personnel are repeatedly exposed to occupational stressors and potentially traumatic events, placing them at elevated risk for post-traumatic stress symptoms (PTSS), burnout, anxiety, and related impairments. Current stress-reduction approaches for healthcare workers often have limited evidence for efficacy or may be difficult to implement in high-demand emergency and healthcare settings. Therefore, rapid, low-burden interventions that are feasible, tolerable, and safe for this population are needed.

Floatation-REST, or Reduced Environmental Stimulation Therapy, is a non-pharmacological intervention that reduces sensory input to the nervous system through the act of floating supine in a pool of warm water saturated with Epsom salt. The float environment is designed to reduce visual, auditory, thermal, tactile, vestibular, and proprioceptive stimulation. Prior studies suggest that Floatation-REST may acutely reduce stress and anxiety-related symptoms, but it has not yet been systematically evaluated in frontline healthcare workers with elevated PTSS.

This single-site, double-arm pilot study will examine the feasibility, tolerability, and safety of two 60-minute sessions of Floatation-REST compared with a documentary-viewing condition in adults ages 18 to 64 with work-related post-traumatic stress symptoms. Up to 30 participants will be recruited, with the goal of retaining 15 completers randomized on a 2:1 basis to Floatation-REST versus comparator condition. Participants will complete two in-person study visits at the Laureate Institute for Brain Research, including self-report questionnaires, blood and saliva collection, functional magnetic resonance imaging scans, and either Floatation-REST or documentary viewing. Follow-up surveys will be completed virtually up to one week after final intervention session.

The primary aim is to evaluate the safety and tolerability of Floatation-REST in this population. Secondary aims will explore whether Floatation-REST is associated with acute changes in PTSS, perceived stress, anxiety, burnout, mood, mindfulness, and moral injury-related distress. Exploratory aims will examine whether changes in brain network connectivity, salivary cortisol, and blood-based proteomic markers may help explain symptom change. Results from this early-stage study will help determine whether Floatation-REST should be further studied as a potential intervention for post-traumatic stress symptoms in frontline healthcare and emergency personnel.

03

Conditions studied

  • Posttraumatic Stress Symptoms
  • Burnout
  • Burnout, Healthcare Workers
  • First Responders
  • PTSD
  • Healthcare Workforce Well-Being
  • Post-traumatic Stress Symptoms

Keywords

  • Floatation-REST
  • Posttraumatic Stress Symptoms
  • PTSD
  • First Responders
  • Burnout
  • Healthcare Workers
  • Emergency Medical Personnel
  • Occupational Stress
  • Post-traumatic Stress Symptoms
04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Work-related post-traumatic stress dysfunction as measured by either of the following inclusion pathways:

    (A) PTSS Pathway: PCL-5 greater than or equal to 20, OR meets criteria for full or partial PTSD on the MINI International Neuropsychiatric Interview 7 () (Criteria A + at least 2 B-E Criteria) OR (B) Functionally Anchored Pathway: evidence of work-related trauma exposure on the MINI International Neuropsychiatric Interview 7 (DSM-V) (Criterion A) or Life Events Checklist-5, and at least one of the following: Moral Injury and Distress Scale greater than or equal to 27, Sheehan Disability Scale greater than or equal to 5 on at least 1 of the 3 subscales, high or very high level of perceived stress (measured by PhenX Perceived Stress Scale greater than or equal to 16).

  2. First responder or other emergency medical personnel
  3. Ability to read, speak and understand English
  4. Capable of providing consent

Exclusion criteria

Exclusion Criteria:

  1. History of neurological conditions
  2. Skin conditions or open wounds
  3. diagnosis of psychotic spectrum disorders, obsessive-compulsive disorder, bipolar disorder, severe substance use disorder, or eating disorder
  4. Inability to lay comfortably in a shallow pool of water
  5. Failure to adhere to "pre-float checklist"
  6. Breathalyzer test positive for alcohol or a drug-positive urine test
  7. Unwillingness to provide consent or complete major aspects of protocol
  8. MRI
  9. Unstable medical diagnoses
  10. Pregnancy
  11. Evidence of inability to comply with study procedures based on experimenter judgement
  12. Change in the dose or prescription of a medication within the 6 weeks before enrolling in the study that could affect brain functioning (e.g., anxiolytics, antipsychotics, antidepressants, benzodiazepines, or mood stabilizers)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Floatation-REST

    Participants will float supine in a shallow pool for two one-hour sessions approximately seven days apart.

    Behavioral: Floatation-REST

  • Active comparator
    Documentary Condition

    Participants will watch two one-hour documentaries in a relaxing environment approximately seven days apart.

    Behavioral: Documentary

Interventions

  • BehavioralFloatation-REST

    Participants float supine in a shallow pool of water saturated with Epsom salt. The environment is designed to minimize external stimulation via multiple channels including sound, light, and temperature.

  • BehavioralDocumentary

    Participants will sit in a quiet room and watch a documentary.

06

What researchers measure

Primary outcomes

  1. Adverse effects

    Safety will be assessed using adverse events reported directly to study staff and adverse effects reported on the Floatation-REST effects checklist after each Floatation-REST or comparator session. As a proxy of safety, adverse effects will be calculated for each participant as the number of instances during the study in which the participant reports an increase above mild for any negatively experienced effect on the checklist.

    Time frame: From baseline to post-intervention seven day follow-up

  2. Dropout Rate

    As a proxy for tolerability, dropout rate for each arm = (# of subjects who are withdrawn from the study)/(# participants in specific arm).

    Time frame: Baseline through seven day post-intervention follow up

Secondary outcomes

  1. Burnout Effects of Floatation-REST

    Burnout measured using the MBI-HSS questionnaire after each experimental session and at follow-up time points

    Time frame: Baseline through seven day post-intervention follow up

  2. Perceived Stress Effects of Floatation-REST

    Perceived stress measured using the Perceived Stress Scale after each experimental session and at follow-up time points

    Time frame: Baseline through seven day post-intervention follow up

  3. Moral Injury Effects of Floatation-REST

    Moral injury measured using the Moral Injury and Distress Scale after each experimental session and at follow-up time points

    Time frame: Baseline through seven day post-intervention follow up

  4. Depressive Symptomatology Effects of Floatation-REST

    Depressive symptoms measured using the Quick Inventory of Depressive Symptomatology (QIDS-SR) after each experimental session and at follow-up time points

    Time frame: Baseline through seven day post-intervention follow up

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Jul 17, 2026
StartActual
Jun 10, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jul 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07710417
Lead sponsor
Laureate Institute for Brain Research, Inc.
Responsible party
adrienne taren (Associate Investigator, Laureate Institute for Brain Research, Inc.) — Principal investigator
First posted
Jul 17, 2026
Start date
Jun 10, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 17, 2026

Study contacts

Adrienne Taren, MD, PhD
Contact
ataren@laureateinstitute.org
918-340-4116
Emily M Choquette, PhD
Contact
echoquette@laureateinstitute.org
918-240-2583

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion